4/A

PRIMARY DOCUMENT

Company: HALOZYME THERAPEUTICS, INC.
Filed: August 26, 2015
Period of Report: August 20, 2015
Accession Number: 0001644348-15-000001

View Document ↗ View on SEC.gov ↗